These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21485816)

  • 1. Attenuating risks through regulation: issues for nanotechnology in India.
    Barpujari I
    J Biomed Nanotechnol; 2011 Feb; 7(1):85-6. PubMed ID: 21485816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cradle-to-grave at the nanoscale: gaps in U.S. regulatory oversight along the nanomaterial life cycle.
    Beaudrie CE; Kandlikar M; Satterfield T
    Environ Sci Technol; 2013 Jun; 47(11):5524-34. PubMed ID: 23668487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.
    Fan AM; Alexeeff G
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8646-57. PubMed ID: 21121378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transnational models for regulation of nanotechnology.
    Marchant GE; Sylvester DJ
    J Law Med Ethics; 2006; 34(4):714-25. PubMed ID: 17199813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necessity and approach to integrated nanomaterial legislation and governance.
    Wang J; Gerlach JD; Savage N; Cobb GP
    Sci Total Environ; 2013 Jan; 442():56-62. PubMed ID: 23178764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Don't define nanomaterials.
    Maynard AD
    Nature; 2011 Jul; 475(7354):31. PubMed ID: 21734686
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanotechnology. EPA ponders voluntary nanotechnology regulations.
    Service RF
    Science; 2005 Jul; 309(5731):36. PubMed ID: 15994499
    [No Abstract]   [Full Text] [Related]  

  • 10. Tighter nanotech regulations touted.
    Sanderson K
    Nature; 2009 Feb; 457(7230):647. PubMed ID: 19194417
    [No Abstract]   [Full Text] [Related]  

  • 11. Technology: Nanomaterials need flexible regulation.
    Wickson F
    Nature; 2011 Aug; 476(7360):283. PubMed ID: 21850092
    [No Abstract]   [Full Text] [Related]  

  • 12. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a more effective and efficient governance and regulation of nanomaterials.
    Teunenbroek TV; Baker J; Dijkzeul A
    Part Fibre Toxicol; 2017 Dec; 14(1):54. PubMed ID: 29258600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too small for concern? Public health and nanotechnology.
    Bowman DM; Fitzharris M
    Aust N Z J Public Health; 2007 Aug; 31(4):382-4. PubMed ID: 17725022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of toxicity testing costs on nanomaterial regulation.
    Choi JY; Ramachandran G; Kandlikar M
    Environ Sci Technol; 2009 May; 43(9):3030-4. PubMed ID: 19534109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The continuing uncertainty of nano risks and regulations.
    Chatterjee R
    Environ Sci Technol; 2008 Nov; 42(21):7733. PubMed ID: 19031851
    [No Abstract]   [Full Text] [Related]  

  • 18. Historical overview of nanotechnology and nanotoxicology.
    Santamaria A
    Methods Mol Biol; 2012; 926():1-12. PubMed ID: 22975953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors: Nanomaterials should be defined.
    Stamm H
    Nature; 2011 Aug; 476(7361):399. PubMed ID: 21866144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.